Stanford African Scholars in Global Health Program (2024/2025)

Stanford Center for Innovation in Global Health invites applications from mid-career licensed African physicians working at an academic institution in an African country and seeking to improve health outcomes by gaining and implementing a new skill set.

For this unique fellowship focused on bidirectional learning and equitable partnerships, selected fellows will spend six weeks at Stanford during the 2024-25 academic year to develop a skill to help improve a specific health outcome at their institution. Cohort 1 will be at Stanford from January to February 2025; Cohort 2 will travel from April to May 2025.

WORTH

• While at Stanford, fellows will be appointed as visiting instructors and will have the opportunity to earn continuing medical education credits.
• They will then receive a generous Pfizer grant of up to $50,000 and ongoing mentorship for 12-18 months to implement a clinical improvement project at their home institution, building upon the skills developed at Stanford.
• The fellowship will culminate with a presentation at a convening to be held in an African country at a later date.

ELIGIBILITY

To be considered, applicants must meet all the following eligibility criteria:

• Be in good standing within their institutions and demonstrate an ongoing commitment to improving health outcomes in their home countries.
• Be an African citizen who is currently living, teaching and practicing clinically in an African country.
• Be a board-certified medical doctor with one of the following degrees (MD, MBChB or MMed).
• Be a mid-career physician, appointed as a faculty member for at least 3 and less than 15 years.
• Have strong working proficiency in written and spoken English (as determined by the selection committee).
• This program is open to physicians from all specialties and primary care who seek a specific skill to improve health outcomes at their institution.
• The program prioritizes those from Sub-Saharan Africa interested in the fields of antimicrobial resistance, oncology, vaccine uptake, or inflammatory diseases.

DEADLINE: February 25, 2024

To apply and for more information, click here.